Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-29
Closed -$2.85K 1219
2025
Q2
$2.85K Buy
+29
New +$2.74K ﹤0.01% 527

Other funds holding AMED

Kilter Group's AMED Position: Q3 2025 in Review

Kilter Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 29 shares — an estimated $2.85K sold.

Kilter Group first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $2.85K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Kilter Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Kilter Group sold 29 Amedisys shares in Q3 2025, an estimated $2.85K.
  • Kilter Group first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Kilter Group's Amedisys position peaked at $2.85K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Kilter Group's 13F filing for Q3 2025, filed 6 Feb 2026.